Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Prognostic Relevance of PCR Positivity in Blood and Bone Marrow in Non-Metastatic Ewings Sarcoma

NCT00339898 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00339898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00339898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Prognostic Relevance of PCR Positivity in Blood and Bone Marrow in Non-Metastatic Ewings Sarcoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
March 12, 2004
Completion date
January 13, 2015
Enrollment
414 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-metastatic ewings sarcoma